"Get leading-edge cancer care in Carmel at IU Health Schwarz Cancer Center. Learn how we provide advanced diagnostic and personalized treatment for many cancers."

During the past decade, IU Health Joe and Shelly Schwarz Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IU Health Joe and Shelly Schwarz Cancer Center" #1 sponsor was "Indiana University" with 6 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Infinity Pharmaceuticals, Inc." with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "R-Pharm" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IU Health Joe and Shelly Schwarz Cancer Center" #1 collaborator was "US Oncology Research" with 3 trials as a collaborator, "Breast Cancer Research Foundation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "IU Health Joe and Shelly Schwarz Cancer Center" are "Metastatic Breast Cancer" (3 trials), "Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "BRCA1 Mutation" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "IU Health Joe and Shelly Schwarz Cancer Center" in a lesser frequency.

Most popular intervention types in "IU Health Joe and Shelly Schwarz Cancer Center" are "Drug" (7 trials), "Behavioral" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dasatinib" (2 trials), "Ixabepilone" (2 trials), "44 doses of radiation" (1 trials), "54 doses of radiation" (1 trials) and "COVID-19 Vaccination" (1 trials). Other intervention names were less common.

The vast majority of trials in "IU Health Joe and Shelly Schwarz Cancer Center" are 8 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "IU Health Joe and Shelly Schwarz Cancer Center". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in IU Health Joe and Shelly Schwarz Cancer Center, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IU Health Joe and Shelly Schwarz Cancer Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".